Preventing tomorrow's sudden cardiac death today. Part I: Current data on risk stratification for sudden cardiac death

American Heart Journal

Volumn 153, Issue 6, 2007, Pages 941-950

  Al Khatib, Sana M ^a   Sanders, Gillian D ^a   Bigger, J Thomas ^b   Buxton, Alfred E ^c   Califf, Robert M ^a   Carlson, Mark ^d   Curtis, Anne ^e   Curtis, Jeptha ^f   Fain, Eric ^d   Gersh, Bernard J ^g   Gold, Michael R ^h   Haghighi Mood, Ali ⁱ   Hammill, Stephen C ^g   Healey, Jeff ^j   Hlatky, Mark ^k   Hohnloser, Stefan ^l   Kim, Raymond J ^a   Lee, Kerry ^a   Mark, Daniel ^a   Mianulli, Marcus ^m   Mitchell, Brent ⁿ   Prystowsky, Eric N ^o   Smith, Joseph ^p   Steinhaus, David ^m   Zareba, Wojciech ^q   more..

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d ST JUDE MEDICAL   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

ⁱ Cambridge Heart Inc   (United States)

^j MCMASTER UNIVERSITY   (Canada)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l GOETHE UNIVERSITY   (Germany)

^m MEDTRONIC INC   (United States)

ⁿ LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^o ST VINCENT HOSPITAL   (United States)

^p Boston Scientific Corp   (United States)

^q UNIVERSITY OF ROCHESTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOSTATISTICS; CARDIAC PATIENT; CLINICAL PRACTICE; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; ECONOMICS; ELECTROCARDIOGRAM; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGING SYSTEM; MEDICARE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; QUALITY CONTROL; RISK FACTOR; STRATIFICATION; SUDDEN DEATH; T WAVE;

ARRHYTHMIA; BAROREFLEX; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; GENETIC SCREENING; HUMANS; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR;

EID: 34249294835     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.003     Document Type: Article

References (90)

1. Zipes D.P., and Wellens H.J.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
2. Gilman J.K., Jalal S., and Naccarelli G.V. Predicting and preventing sudden death from cardiac causes. Circulation 90 (1994) 1083-1092
3. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119 (1993) 1187-1197
4. Zheng Z.-J., Croft J.B., Giles E.H., et al. Sudden cardiac death in the United States, 1989-1998. Circulation 104 (2001) 2158-2163
5. Huikuri H.V., Makikallio T.H., Raatikainen M.J., et al. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108 (2003) 110-115
6. American Heart Association. Heart Disease and Stroke Statistics-2003 update (2002), American Heart Association, Dallas (TX)
7. Moss A.J., Hall W.J., Cannom D.S., et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 335 (1996) 1933-1940
8. Bigger Jr. J.T., and for the Coronary Artery Bypass Graft (CABG) Patch trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
9. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial investigators. N Engl J Med 341 (1999) 1882-1890
10. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
11. Kadish A., Dyer A., Daubert J.P., et al., for the Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
12. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
13. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
14. Singh J.P., Hall W.J., McNitt S., et al., for the MADIT-II Investigators. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 46 (2005) 1712-1720
15. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
16. Lee K.L., Pryor D.B., Harrell Jr. F.E., et al. Predicting outcome in coronary disease. Statistical models versus expert clinicians. Am J Med 80 (1986) 553-560
17. Hohnloser S.H., and Gersh B.J. Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator. Circulation 107 (2003) 941-946
18. Nelson G.R., Cohn P.F., and Gorlin R. Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parameters. Circulation 52 (1975) 408-412
19. Schulze R.A., Strauss H.W., and Pitt B. Sudden death in the year following myocardial infarction Relation to ventricular premature contractions in the late hospital phase and left ventricular ejection fraction. Am J Med 62 (1977) 192-199
20. Multicenter Post Infarction Research Group. Risk Stratification and survival after myocardial infarction. N Engl J Med 309 (1983) 331-336
21. Solomon S., Zelenkofske S., McMurray J.J.V., et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
22. Grimm W., Christ M., Bach J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study. Circulation 108 (2003) 2883-2891
23. MERIT HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
24. Al-Khatib S.M., Sanders G.D., Mark D.B., et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 149 (2005) 1020-1034
25. Anderson K.P., DeCamilla J., and Moss A.J. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation 57 (1978) 890-897
26. Bigger Jr. J.T., Fleiss J.L., Kleiger R., et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69 (1984) 250-258
27. Mäkikallio T.H., Barthel P., Schneider R., et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 26 (2005) 762-769
28. Grimm W., Christ M., and Maisch B. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. PACE 28 Suppl 1 (2005) S207-S210
29. Klingenheben T., Zabel M., D'Agostino R.B., et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
30. Costantini O., Drabek C., and Rosenbaum D.S. Can sudden cardiac death be predicted from the T wave of the ECG? A critical examination of T wave alternans and QT interval dispersion. PACE 23 (2000) 1407-1416
31. Gold M.R., and Spencer W. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol 18 (2003) 1-5
32. Kavesh N.G., Shorofsky S.R., Sarang S.E., et al. Effect of heart rate on T wave alternans. J Cardiovasc Electrophysiol 9 (1998) 703-708
33. Rosenbaum D.S., Jackson L.E., Smith J.M., et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
34. Gold M., Bloomfield D.M., Anderson K.P., et al. A comparison of T-wave alternans, signal-averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36 (2000) 2247-2253
35. Gehi A.K., Stein R.H., Metz L.D., et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
36. Chow T., Kereiakes D.J., Barmodulation C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
37. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
38. Gold M.R., Ensley D., Chilson D., et al. T-Wave alternans SCD HeFT study: primary endpoint analysis. Circulation 114 (2006) 428
39. www.theheart.org/article/755871.do. Accessed on 11/16/06.
40. van Ravenswaaij-Arts C.M., Kollee L.A., Hopman J.C., et al. Heart rate variability. Ann Int Med 118 (1993) 436-447
41. Kleiger R.E., Miller J.P., Bigger Jr. J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
42. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
43. La Rovere M.T., Pinna G.D., Maestri R., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107 (2003) 565-570
44. Frenneaux M.P. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart 90 (2004) 1248-1255
45. Huikuri V.H., Tapanainen J.M., Lindgren K., et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 42 (2003) 652-658
46. Schmidt D., Malik M., Barthel P., et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353 (1999) 1390-1396
47. Berkowitsch A., Zareba W., Neumann T., et al. Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10 minute Holter recording. Ann Noninvasive Electrocardiol 9 (2004) 270-279
48. Grimm W., Schmidt G., Maisch B., et al. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 14 (2003) 819-824
49. Bauer A., Kantelhardt J.W., Barthel P., et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367 (2006) 1674-1681
50. Moss A.J., Schwartz P.J., Crampton R.S., et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84 (1991) 1136-1144
51. Moss A.J., Zareba W., Kaufman E.S., et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105 (2002) 794-799
52. Zareba W., Moss A.J., le Cessie S., et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 26 (1995) 1685-1691
53. Padmanabhan S., Silvet H., Amin J., et al. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results from a cohort of 2265 patients with an ejection fraction of ≤40%. Am Heart J 145 (2003) 132-138
54. Gang Y., Ono T., Hnatkova K., et al. QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II sub-study. PACE 26 (2003) 394-400
55. Straus S.M., Kors J.A., De Bruin M.L., et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47 (2006) 362-367
56. Brendorp B., Elming H., Jun L., et al. Dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation 103 (2001) 831-835
57. Haigney M.C., Zareba W., Gentlesk P.J., et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 44 (2004) 1481-1487
58. El-Sherif N., Denes P., Katz R., et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. J Am Coll Cardiol 25 (1995) 908-914
59. Kuchar D.L., Thorburn C.W., and Sammel N.L. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol 9 (1987) 531-538
60. Gomes J.A., Winters S.L., Martinson M., et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol 13 (1989) 377-384
61. Steinberg J.S., Regan A., Sciacca R.R., et al. Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol 68 (1992) 13-21
62. Breithardt G., Schwarmaier J., Borggrefe M., et al. Prognostic significance of late ventricular potentials after acute myocardial infarction. Eur Heart J 4 (1983) 487-495
63. Ohnishi Y., Inoue T., and Fukuzaki H. Value of the signal-averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy. Jpn Circ J 54 (1990) 127-136
64. Gomes J.A., Cain M.E., Buxton A.E., et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104 (2001) 436-441
65. Bourke J.P., Richards D.A., Ross D.L., et al. Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol 18 (1991) 780-788
66. Iesaka Y., Nogami A., Aonuma K., et al. Prognostic significance of sustained monomorphic ventricular tachycardia induced by programmed ventricular stimulation using up to triple extrastimuli in survivors of acute myocardial infarction. Am J Cardiol 65 (1990) 1057-1063
67. Nogami A., Aonuma K., Takahashi A., et al. Usefulness of early versus late programmed ventricular stimulation in acute myocardial infarction. Am J Cardiol 68 (1991) 13-20
68. Buxton A.E., Lee K.L., DiCarlo L., et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 342 (2000) 1937-1945
69. Daubert J.P., Zareba W., Hall W.J., et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 47 (2006) 98-107
70. Poll D.S., Marchlinksi F.E., Buxton A.E., et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 58 (1986) 992-997
71. Das S.K., Morady F., DiCarlo Jr. L., et al. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 58 (1986) 998-1000
72. Chen X., Shenasa M., Borggrefe M., et al. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J 15 (1994) 76-82
73. Grimm W., Hoffmann J., Menz V., et al. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 32 (1998) 739-745
74. Habash-Bseiso D.E., Rokey R., Berger C.J., et al. Accuracy of noninvasive ejection fraction measurement in a large community-based clinic. Clin Med Res 3 (2005) 75-82
75. Hoffmann R., von Bardeleben S., ten Cate F., et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 26 (2005) 607-616
76. Lim T.K., Burden L., Janardhanan R., et al. Contrast echocardiography versus gated single photon emission computed tomography for the assessment of parameters of left ventricular remodeling after acute myocardial infarction. J Am Soc Echocardiogr 19 (2006) 280-284
77. Bello D., Fieno D.S., Kim R.J., et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 (2005) 1104-1108
78. Ricciardi M., Wu E., Davidson C., et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103 (2001) 2780-2783
79. Simonetti O., Kim R., Fieno D., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 214-223
80. Wu E., Judd R., Vargas J., et al. Visualisation of presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 (2001) 21-28
81. Nazarian S., Bluemke D.A., Lardo A.C., et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 (2005) 2821-2825
82. Kwong R.Y., Chan A.K., Brown K.A., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006) 2733-2743
83. Arking D.E., Chugh S.S., Chakravarti A., et al. Genomics in sudden cardiac death. Circ Res 94 (2004) 712-723
84. Spooner P.M., Albert C., Benjamin E.J., et al. Sudden cardiac death, genes, and arrhythmogenesis consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute Workshop, Part I. Circulation 103 (2001) 2361-2364
85. Splawski I., Timothy K.W., Tateyama M., et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297 (2002) 1333-1336
86. Napolitano C., Priori S.G., Schwartz P.J., et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 294 (2005) 2975-2980
87. Spooner P.M., Albert C., Benjamin E.J., et al. Sudden cardiac death, genes, and arrhythmogenesis consideration of new population and mechanistic approaches from a national heart, lung and blood institute workshop, part II. Circulation 103 (2001) 2447-2452
88. Tapanainen J.M., Lindgren K.S., Mäkikallio T.H., et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 43 (2004) 757-763
89. Koenig W., Löwel H., Baumert J., et al. C-reactive protein modulates risk prediction based on the Framingham score implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109 (2004) 1349-1353
90. www.accncdr.com/WebNCDR/ICD/RESEARCH.ASPX.